Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study

T. Dinh, L.H.B. Baur, R. Pisters, O. Kamp, F.W.A. Verheugt, J.L.R.M. Smeets, E.C. Cheriex, J.E. Lindeboom, W.F. Heesen, R.G. Tieleman, M.H. Prins, H.J.G.M. Crijns, the TIARA investigators

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)

Abstract

Objective Current stroke risk schemes need improvement of predictive value in patients with atrial fibrillation. Transoesophageal echocardiography (TEE) may facilitate stroke risk assessment in such patients and guide antithrombotic treatment.

Methods We randomised 238 patients with non-valvular atrial fibrillation and a moderate stroke risk to aspirin or adjusted vitamin K antagonist therapy after TEE had ruled out thrombogenic features in the atria and aorta. The primary outcome was a composite of stroke, major bleeding, peripheral embolism and all-cause mortality.

Results Mean CHA(2)DS(2)-VASc score was 2.11.1. The incidences of the composite primary outcome at a mean follow-up of 1.6years were 3.2% (2.02% per year) in the aspirin group compared to 6.1% (3.84% per year) in the vitamin K antagonists group with an absolute advantage of 2.9 percentage points. Aspirin was non-inferior to vitamin K antagonists (p

Conclusions This hypothesis-generating pilot trial has found that TEE may be used for refinement of stroke risk in paroxysmal atrial fibrillation patients. A larger trial is needed to confirm these data. (ClinicalTrials.gov number NTC00224757).

Original languageEnglish
Pages (from-to)563-568
Number of pages6
JournalHeart
Volume100
Issue number7
DOIs
Publication statusPublished - 1 Apr 2014

Keywords

  • RANDOMIZED CONTROLLED-TRIAL
  • EURO HEART SURVEY
  • RISK STRATIFICATION
  • ORAL ANTICOAGULATION
  • STROKE PREVENTION
  • PREDICTING STROKE
  • CLINICAL RISK
  • WARFARIN
  • DABIGATRAN
  • THROMBOEMBOLISM

Cite this

Dinh, T., Baur, L. H. B., Pisters, R., Kamp, O., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Lindeboom, J. E., Heesen, W. F., Tieleman, R. G., Prins, M. H., Crijns, H. J. G. M., & TIARA investigators, T. (2014). Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study. Heart, 100(7), 563-568. https://doi.org/10.1136/heartjnl-2013-305017